9005:TSETOKYU CORPORATION Analysis
Data as of 2026-06-05 - not real-time
¥1,682.50
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Tokyu Corporation is trading below its 50‑day and 200‑day moving averages, indicating a bearish medium‑term price trend, while the 20‑day SMA sits just under the current price, offering a modest near‑term support. The RSI hovers around the mid‑50s, suggesting neither overbought nor oversold conditions, and the MACD histogram is positive, hinting at a potential short‑term bullish reversal.
Fundamentally, the company delivers solid revenue growth of roughly twelve percent and a respectable dividend yield near two percent, yet its free cash flow is negative and debt‑to‑equity exceeds 140%, raising concerns about sustainability. The discounted cash‑flow model values the stock well below the market price, implying that the shares are currently overvalued despite a modest payout ratio.
Fundamentally, the company delivers solid revenue growth of roughly twelve percent and a respectable dividend yield near two percent, yet its free cash flow is negative and debt‑to‑equity exceeds 140%, raising concerns about sustainability. The discounted cash‑flow model values the stock well below the market price, implying that the shares are currently overvalued despite a modest payout ratio.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below 50‑day and 200‑day SMAs signaling bearish bias
- Positive MACD histogram suggesting a possible short‑term bounce
- Support level near the 20‑day SMA provides a floor
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Steady revenue growth and dividend yield attractive for income investors
- High leverage and negative free cash flow increase financial risk
- Market price exceeds DCF fair value, indicating overvaluation
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Significant overvaluation relative to intrinsic DCF estimate
- Elevated debt‑to‑equity ratio and ongoing cash‑flow deficit
- Sector exposure to consumer cyclicality may exacerbate downside risk
Key Metrics & Analysis
Financial Health
Revenue Growth12.00%
Profit Margin8.02%
P/E Ratio19.9
ROE9.72%
ROA2.30%
Debt/Equity144.32
P/B Ratio1.1
Op. Cash Flow¥127.7B
Free Cash Flow¥-60252250112
Technical Analysis
TrendBearish
RSI52.7
Support¥1,580.00
Resistance¥1,721.50
MA 20¥1,637.65
MA 50¥1,744.52
MA 200¥1,805.61
MACDBullish
VolumeIncreasing
Fear & Greed Index93.93
Valuation
Fair Value¥1,133.87
Target Price¥2,144.29
Upside/Downside27.45%
GradeOvervalued
TypeBlend
Dividend Yield1.92%
Risk Assessment
Beta-0.01
Volatility20.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.